Todd Corenson
Founder @ Enlon
Los Gatos, United States
Todd Corenson is a seed investor at Enlon in Los Gatos focused on Biotechnology and FinTech. Todd Corenson - Founder @ Enlon
- Total investments:
- 10
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Todd Corenson invests in
Stages Todd Corenson invests in
Countries Todd Corenson invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $1M–$4.4M
- Convertible Note
- $50k–$50k
Investment Focus
Industry
- Biotechnology 4 (40%)
- FinTech 3 (30%)
- SaaS 2 (20%)
- Chemical 2 (20%)
- Biopharma 2 (20%)
Stage
- Seed 6 (60%)
- Pre-Seed 1 (10%)
- Convertible Note 1 (10%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
HelixNano
|
Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases. HelixNano is a Y Combinator and venture backed biotech startup. At HelixNano, we have spent the last two years developing cancer vaccines. Now we are adapting our synthetic biology arsenal to take on COVID-19. We’re moving fast but thinking long-term. We’re alreadytesting COVID-19 vaccine candidates designed to be precise and safe. Our next goal is to create a vaccine that protects everyone not only from this virus, but all future coronaviruses. | $50K / Convertible Note / Dec 08, 2017 | |
Solugen
|
Solugen's mission is to decarbonize the chemicals industry. Solugen combines synthetic biology with metal catalysis to make carbon negative chemicals at scale.Solugen's patented approach takes advantage of bio-inspired reactions to use plant material as a low-cost feedstock to produce novel products cost-competitive with thecompetition. | $4.4M / Seed / Oct 24, 2017 | |
|
HelixNano
|
Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases. HelixNano is a Y Combinator and venture backed biotech startup. At HelixNano, we have spent the last two years developing cancer vaccines. Now we are adapting our synthetic biology arsenal to take on COVID-19. We’re moving fast but thinking long-term. We’re alreadytesting COVID-19 vaccine candidates designed to be precise and safe. Our next goal is to create a vaccine that protects everyone not only from this virus, but all future coronaviruses. | $50K / Convertible Note / Aug 26, 2017 | |
iMicrobes
|
Industrial Microbes designs and builds microbes that produce better chemicals with lower costs and lower carbon emissions. We use greenhouse gases as the raw materials, including biogas, natural gas, and carbon dioxide. We scale our process with global chemical producers. | $120K / Pre-Seed / Jun 15, 2015 | |
Direct Match
|
Direct Match was a venture-backed startup building the first all-to-all US Treasury trading venue. | $3M / Seed / May 07, 2015 | |
Ginkgo Bioworks
|
Ginkgo Bioworks is a biotechnology firm. It is a developer of biological engineering products and custom microbes across multiple markets. It designs, engineer, develops, tests, and licenses organisms. It discovers molecules in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. It also provides probiotic bacteria toprotect the body from dangerous infections, and it generates libraries of molecules. It serves cultured ingredients, carbon mitigation, probiotics, and natural product discovery markets. | $1M / Seed / Jul 16, 2014 | |
Amplitude
|
Amplitude is the product intelligence platform that helps companies use their customer data to build great product experiences for systematic business growth. Headquartered in San Francisco with offices in New York, London, Paris, Amsterdam, and Singapore, Amplitude is the cross-platform intelligence solution of choice for modern product and growthteams. Amplitude serves over 30,000 teams at companies like Microsoft, Twitter, Adidas, CapitalOne, NBC, Hubspot, and Procter & Gamble. | $2M / Seed / Jul 11, 2014 | |
Robinhood
|
Robinhood is a stock brokerage that allows customers to buy and sell stocks, options, ETFs, and cryptocurrencies with zero commission. | $3M / Seed / Dec 01, 2013 | |
Carta
|
Carta is a transfer agent for private companies that enables seed-stage to pre-IPO companies to manage equity electronically with the participation of their shareholders, employees, auditors, and legal counsel. It digitizes paper stock certificates along with stock options, warrants, and derivatives to create a real-time image of who owns what at astartup.Carta receives funding from a group of investors, including Draper VC, Expansion VC, k9 Ventures, Elefund, Subtraction Capital, Scott Banister, XG Ventures, Kima Ventures, Andy Palmer, and Structure Capital.It was founded by Manu Kumar and Henry Ward in 2012 as eShares, Carta is based in Mountain View, California. | $1.8M / Seed / Aug 13, 2013 | |
|
Carta
|
Carta is a transfer agent for private companies that enables seed-stage to pre-IPO companies to manage equity electronically with the participation of their shareholders, employees, auditors, and legal counsel. It digitizes paper stock certificates along with stock options, warrants, and derivatives to create a real-time image of who owns what at astartup.Carta receives funding from a group of investors, including Draper VC, Expansion VC, k9 Ventures, Elefund, Subtraction Capital, Scott Banister, XG Ventures, Kima Ventures, Andy Palmer, and Structure Capital.It was founded by Manu Kumar and Henry Ward in 2012 as eShares, Carta is based in Mountain View, California. | $1.8M / Seed / Aug 13, 2013 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Todd Corenson invest in?
Todd Corenson invests primarily in Biotechnology, FinTech and SaaS startups, most often at Seed and Pre-Seed stage. Most of the 10 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Todd Corenson's check size?
Todd Corenson typically joins rounds of $1M–$4.4M at Seed and $50k–$50k at Convertible Note. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Todd Corenson participates in.
How do I contact Todd Corenson?
Public channels for Todd Corenson include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Todd Corenson last invest?
The most recent investment recorded for Todd Corenson closed in Dec 2017. Shizune tracks 10 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
